FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Hadley

Research Profile

Concepts & Ideas

Luminescent Measurements

Chemicals & Drugs

Anatomy

Disorders

Procedures

Rosette Formation

Physiology

Living Beings

Newborn Infant

Co-author Network

Publications

TOP 3
Craig P Turner; Andrew G Hadley
The role of P-selectin in the immune destruction of platelets.
Andrew G Hadley; A Wilkes; J Poole; P Arndt; George Garratty
A chemiluminescence test for predicting the outcome of transfusing incompatible blood.
Andrew G Hadley; A Wilkes; J Goodrick; D Penman; Peter W Soothill; G Lucas
The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Hadley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Craig P Turner; Andrew G Hadley
The role of P-selectin in the immune destruction of platelets.
British journal of haematology 2003;121(4):623-31.
1999: Andrew G Hadley; A Wilkes; J Poole; P Arndt; George Garratty
A chemiluminescence test for predicting the outcome of transfusing incompatible blood.
Transfusion medicine (Oxford, England) 1999;9(4):337-42.
1998: Andrew G Hadley; A Wilkes; J Goodrick; D Penman; Peter W Soothill; G Lucas
The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn.
British journal of obstetrics and gynaecology 1998;105(2):231-4.
1998: Andrew G Hadley
A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
Vox sanguinis 1998;74 Suppl 2():375-83.
1997: S L Shepard; Andrew G Hadley
Monocyte-bound monoclonal antibodies inhibit the Fc gamma RI-mediated phagocytosis of sensitized red cells: the efficiency and mechanism of inhibition are determined by the nature of the antigen.
Immunology 1997;90(2):314-22.
1996: Belinda M Kumpel; J G van de Winkel; N A Westerdaal; Andrew G Hadley; J M Dugoujon; Antoine BLANCHER
Antigen topography is critical for interaction of IgG2 anti-red-cell antibodies with Fc gamma receptors.
British journal of haematology 1996;94(1):175-83.
1996: D Filbey; S F Garner; Andrew G Hadley; S L Shepard
Quantitative and functional asessment of anti-RhD: a comparative study of non-invasive methods in antenatal prediction of Rh hemolytic disease.
Acta obstetricia et gynecologica Scandinavica 1996;75(2):102-7.
1996: Andrew G Hadley; G D Poole; Joyce Poole; N A Anderson; M Robson
Haemolytic disease of the newborn due to anti-G.
Vox sanguinis 1996;71(2):108-12.
1996: S L Shepard; A L Noble; D Filbey; Andrew G Hadley
Inhibition of the monocyte chemiluminescent response to anti-D-sensitized red cells by Fc gamma RI-blocking antibodies which ameliorate the severity of haemolytic disease of the newborn.
Vox sanguinis 1996;70(3):157-63.
1995: Andrew G Hadley; Barbara Zupanska; Belinda M Kumpel; C Pilkington; H L Griffiths; K A Leader; J Jones; David J Booker; Robert Stamps; R J Sokol
The glycosylation of red cell autoantibodies affects their functional activity in vitro.
British journal of haematology 1995;91(3):587-94.
1995: Andrew G Hadley
In vitro assays to predict the severity of hemolytic disease of the newborn.
Transfusion medicine reviews 1995;9(4):302-13.
1995: A L Noble; G D Poole; N Anderson; GF Lucas; Andrew G Hadley
Predicting the severity of haemolytic disease of the newborn: an assessment of the clinical usefulness of the chemiluminescence test.
British journal of haematology 1995;90(3):718-20.
1995: Belinda M Kumpel; Y Wang; H L Griffiths; Andrew G Hadley; Graham Rook
The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment.
Human antibodies and hybridomas 1995;6(3):82-8.
1994: H L Griffiths; Belinda M Kumpel; Christopher J Elson; Andrew G Hadley
The functional activity of human monocytes passively sensitized with monoclonal anti-D suggests a novel role for Fc gamma RI in the immune destruction of blood cells.
Immunology 1994;83(3):370-7.
1994: T Bakács; Andrew G Hadley; Belinda M Kumpel; D M Segal; F Banhidy
Comparison of the ability of red cells sensitized with a bispecific anti-D x anti-Fc gamma RIII Fab fragment to activate human K cells and peritoneal macrophages through Fc gamma RIII.
Immunology letters 1994;42(1-2):91-5.
1993: GF Lucas; Andrew G Hadley; S J Nance; G Garratty
Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test.
Transfusion 1993;33(6):484-7.
1993: Andrew G Hadley; Belinda M Kumpel
The role of Rh antibodies in haemolytic disease of the newborn.
Baillière's clinical haematology 1993;6(2):423-44.
1992: Andrew G Hadley; Barbara Zupanska; Belinda M Kumpel; K A Leader
The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
Immunology 1992;76(3):446-51.
1992: Andrew G Hadley; G D Poole; I D Fraser
Predicting the severity of haemolytic disease of the newborn: prospective evaluation of the chemiluminescence test.
Vox sanguinis 1992;63(4):291-2.
1992: Andrew G Hadley; G D Poole; N W Amphlett; GF Lucas
The use of interferon-gamma-treated U937 cells in chemiluminescence assays to detect red cell, platelet and granulocyte antibodies of potential clinical significance.
Clinical and laboratory haematology 1992;14(4):315-26.
1991: K A Leader; Belinda M Kumpel; Andrew G Hadley; B A Bradley
Functional interactions of aglycosylated monoclonal anti-D with Fc gamma RI+ and Fc gamma RIII+ cells.
Immunology 1991;72(4):481-5.
1991: Andrew G Hadley; K Leader; G Laundy; A Smith; P Klouda; B A Bradley
A rapid solid-phase rosette-inhibition assay for the detection of Fc receptor (FcRII)-blocking alloantibodies [corrected].
Immunology letters 1991;27(3):215-20.
1991: Andrew G Hadley; Belinda M Kumpel; K A Leader; G D Poole; I D Fraser
Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.
British journal of haematology 1991;77(2):221-8.
1990: Andrew G Hadley; Belinda M Kumpel
Functional interactions of erythrocytes sensitized by IgG1 (E-IgG1) and IgG3 (E-IgG3) human monoclonal anti-D with monocytes.
Biochemical Society transactions 1990;18(2):304-5.
1990: Belinda M Kumpel; Andrew G Hadley
Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines.
Molecular immunology 1990;27(3):247-56.
1989: Belinda M Kumpel; K A Leader; A H Merry; Andrew G Hadley; G D Poole; Antoine BLANCHER; D Goossens; N C Hughes-Jones; B A Bradley
Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis.
European journal of immunology 1989;19(12):2283-8.
1989: Andrew G Hadley; Belinda M Kumpel
Synergistic effect of blending IgG1 and IgG3 monoclonal anti-D in promoting the metabolic response of monocytes to sensitized red cells.
Immunology 1989;67(4):550-2.
1989: Andrew G Hadley; Belinda M Kumpel
Phagocytosis by human monocytes of red cells sensitized with monoclonal IgG1 and IgG3 anti-D.
Vox sanguinis 1989;57(2):150-1.
1989: Andrew G Hadley; Belinda M Kumpel; K Leader; A H Merry; Ewa Brojer; Barbara Zupanska
An in-vitro assessment of the functional activity of monoclonal anti-D.
Clinical and laboratory haematology 1989;11(1):47-54.
1989: A H Merry; Ewa Brojer; Barbara Zupanska; Andrew G Hadley; Belinda M Kumpel; N C Hughes-Jones
Ability of monoclonal anti-D antibodies to promote the binding of red cells to lymphocytes, granulocytes and monocytes.
Vox sanguinis 1989;56(1):48-53.
1988: Andrew G Hadley; Belinda M Kumpel; A H Merry
The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies.
Clinical and laboratory haematology 1988;10(4):377-84.
1987: GF Lucas; Andrew G Hadley; A M Holburn
Anti-platelet opsonic activity in alloimmune and autoimmune thrombocytopenia.
Clinical and laboratory haematology 1987;9(1):59-66.
1987: Andrew G Hadley; M A Byron; Helen Chapel; C Bunch; A M Holburn
Anti-granulocyte opsonic activity in sera from patients with systemic lupus erythematosus.
British journal of haematology 1987;65(1):61-5.
1986: Andrew G Hadley; A M Holburn; C Bunch; Helen Chapel
Anti-granulocyte opsonic activity and autoimmune neutropenia.
British journal of haematology 1986;63(3):581-9.
1984: Andrew G Hadley; A M Holburn
The detection of anti-granulocyte antibodies by chemiluminescence.
Clinical and laboratory haematology 1984;6(4):351-61.